¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Çâ, »ê¾÷ ºÐ¼® º¸°í¼­ : À¯Çüº°, Ä¡·á ºÐ¾ßº°, Ž»ö ´Ü°èº°, ÃÖÁ¾ ¿ëµµº°, Áö¿ªº° - ½ÃÀå ¿¹Ãø(2025-2034³â)
Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type, Therapeutic Area, Discovery Phase, End Use, and Region - Market Forecast, 2025-2034
»óǰÄÚµå : 1762248
¸®¼­Ä¡»ç : Polaris Market Research
¹ßÇàÀÏ : 2025³â 05¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 128 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,250 £Ü 5,900,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,250 £Ü 7,288,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ 20¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,250 £Ü 8,676,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

Polaris Market ResearchÀÇ ÃֽŠÁ¶»ç¿¡ µû¸£¸é, ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ¼¼°è ½ÃÀå ±Ô¸ð´Â 2034³â±îÁö 839¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ º¸°í¼­´Â ÇöÀç ½ÃÀå ¿ªÇп¡ ´ëÇÑ ÀÚ¼¼ÇÑ ÀλçÀÌÆ®¿Í ÇâÈÄ ½ÃÀå ¼ºÀå¿¡ ´ëÇÑ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º´Â Áúº´ Áø´Ü, ÀǾàǰ °³¹ß, ¸ÂÃãÀÇ·á¿¡ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ´Â ¹ÙÀÌ¿À¸¶Ä¿ÀÇ ½Äº°, °ËÁõ, °³¹ßÀ» Á¦3ÀÇ ±â°ü°ú °è¾àÇÏ¿© ¼öÇàÇÏ´Â ¼­ºñ½ºÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ¼­ºñ½º´Â ÀǾàǰ °³¹ß ¾÷¹« À§Å¹±â°ü(CRO), »ý¸í°øÇÐ ±â¾÷, Àü¹® ¿¬±¸¼Ò°¡ Á¦°øÇϸç, Á¦¾à±â¾÷°ú ÇコÄÉ¾î ±â¾÷Àº Â÷¼¼´ë ¿°±â¼­¿­ ºÐ¼®, ´Ü¹éÁúüÇÐ, ¹ÙÀÌ¿ÀÀÎÆ÷¸Åƽ½º µî ÷´Ü ±â¼úÀ» Ȱ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿ ¹ß±¼À» ¾Æ¿ô¼Ò½ÌÇÔÀ¸·Î½á ±â¾÷Àº ¿¬±¸°³¹ß(R&D)ÀÇ È¿À²¼ºÀ» ÃÖÀûÈ­Çϰí, ¿î¿µ ºñ¿ëÀ» Àý°¨Çϸç, »õ·Î¿î Ä¡·á¹ýÀÇ ½ÃÀå Ãâ½Ã ½Ã°£À» ´ÜÃàÇÒ ¼ö ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á¿Í Ç¥ÀûÄ¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¹ÙÀÌ¿À¸¶Ä¿´Â ȯÀÚº° Ä¡·á ¹ÝÀÀÀ» ÆÄ¾ÇÇϰí ÀÓ»ó½ÃÇèÀÇ ¼º°ø·üÀ» ³ôÀÌ´Â µ¥ µµ¿òÀÌ µÇ±â ¶§¹®¿¡ ÀÌ·¯ÇÑ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀåÀº ¿¬±¸ Çù·ÂÀÇ Áõ°¡, ÇコÄɾî ÅõÀÚ Áõ°¡, ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý Áø´ÜÀÇ ¹ßÀüÀ¸·Î ÀÎÇØ ²ÙÁØÇÑ ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀåÀº ±â¼ú ¹ßÀü, źźÇÑ Á¦¾à ºÎ¹®, ¿ìÈ£ÀûÀÎ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©¿¡ ÈûÀÔ¾î Å©°Ô ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ÃËÁø¿äÀÎÀ¸·Î´Â ¹ÙÀÌ¿À¸¶Ä¿ ºÐ¼®À» °­È­Çϱâ À§ÇÑ ÀΰøÁö´É(AI)°ú ¸Ó½Å·¯´×ÀÇ Ã¤Åà Áõ°¡, ´Ù¾çÇÑ ¿¬±¸ ¼ö¿ä¸¦ ÃæÁ·½Ã۱â À§ÇÑ ¼­ºñ½º Æ÷Æ®Æú¸®¿ÀÀÇ È®´ë µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ, °³¹ß»çµéÀº È¿À²¼º°ú °æÀï·ÂÀ» Çâ»ó½Ã۱â À§ÇØ Á¦¾à»çµé°úÀÇ Àü·«Àû Á¦ÈÞ¸¦ ¿ì¼±¼øÀ§¿¡ µÎ°í ÀÖ½À´Ï´Ù. ¸ÂÃãÇü ÀÇ·á¿Í ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý ÀǾàǰ °³¹ß¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå °³Ã´ÀÌ °¡¼ÓÈ­µÇ°í ÀÖÀ¸¸ç, Áúº´ ŽÁö ¹× Ä¡·á ÃÖÀûÈ­¸¦ À§ÇÑ Çõ½ÅÀûÀÎ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ±âȸ°¡ âÃâµÇ°í ÀÖ½À´Ï´Ù. Á¤¹ÐÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÔ¿¡ µû¶ó »ý¹°ÀÇÇÐ ¿¬±¸¿Í Ä¡·á¹ý °³¹ßÀ» ¹ßÀü½ÃŰ´Â ÃÖ÷´Ü µµ±¸¿Í ¼­ºñ½º¸¦ Á¦°øÇÏ´Â ½ÃÀåÀº Áö¼ÓÀûÀ¸·Î ¹ßÀüÇÒ Áغñ°¡ µÇ¾î ÀÖ½À´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

À¯Çüº°·Î´Â ´ë¸® Æò°¡ÁöÇ¥°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ´ë¸® Æò°¡º¯¼ö´Â ÀÓ»ó °á°ú¸¦ ³ªÅ¸³»´Â °£Á¢ÀûÀÎ ÁöÇ¥·Î ÀÛ¿ëÇÏ¿© ¿¬±¸ÀÚµéÀÌ ÀǾàǰ °³¹ß °úÁ¤¿¡¼­ Ä¡·áÀÇ È¿°ú¿Í ¾ÈÀü¼ºÀ» º¸´Ù È¿À²ÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖµµ·Ï µ½½À´Ï´Ù.

Ä¡·á ºÐ¾ßº°·Î º¸¸é ¾Ï ºÐ¾ß°¡ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ¾Ï ¹ßº´·üÀÇ Áõ°¡¿Í ¹ÙÀÌ¿À¸¶Ä¿ ±â¹Ý ÀǾàǰ °³¹ßÀÇ Ã¤Åà Ȯ´ë¿¡ ±âÀÎÇÕ´Ï´Ù. ¾ÏÀÇ Á¶±â ¹ß°ß, ¿¹ÈÄ ¿¹Ãø, Ä¡·á¹ý ¼±Åÿ¡ ÀÖ¾î ¹ÙÀÌ¿À¸¶Ä¿ÀÇ È°¿ëÀÌ Àӻ󿬱¸¿¡¼­ ÀÌ ºÐ¾ßÀÇ Á߿伺À» ³ôÀ̰í ÀÖ½À´Ï´Ù.

ºÏ¹Ì°¡ °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¿ìÀ§¼ºÀº ³ôÀº R&D ÅõÀÚ, Á¤¹ÐÀÇ·áÀÇ Á߿伺, Á¦¾à±â¾÷°ú CRO(ÀÓ»ó½ÃÇè¼öʱâ°ü)ÀÇ °ß°íÇÑ Çù·Â°ü°è¿¡ ±âÀÎÇÕ´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀåÀÇ CAGRÀÌ °¡Àå ³ôÀº Áö¿ªÀº ¾Æ½Ã¾ÆÅÂÆò¾çÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±Þ¼ÓÇÑ ¼ºÀåÀº Á¦¾à ±â¾÷ÀÇ R&D Ȱµ¿ Áõ°¡, ÀÓ»ó½ÃÇè ¾÷¹«ÀÇ ±ÞÁõ, Áß±¹ ¹× Àεµ¿Í °°Àº ±¹°¡¿¡¼­ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ºñ¿ë È¿À²ÀûÀÎ ¾Æ¿ô¼Ò½Ì ¼Ö·ç¼Ç¿¡ ±âÀÎÇÕ´Ï´Ù.

¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, Fujirebio Holdings Inc µîÀÌ ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ¼Ò°³

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå Á¶»ç ¹æ¹ý

Á¦4Àå ¼¼°è ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå ÀλçÀÌÆ®

Á¦5Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå : À¯Çüº°

Á¦6Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå : Ä¡·á ºÐ¾ßº°

Á¦7Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå : Ž»ö ´Ü°èº°

Á¦8Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå : ÃÖÁ¾ ¿ëµµº°

Á¦9Àå ¼¼°èÀÇ ¹ÙÀÌ¿À¸¶Ä¿ Ž»ö ¾Æ¿ô¼Ò½Ì ¼­ºñ½º ½ÃÀå : Áö¿ª

Á¦10Àå °æÀï ±¸µµ

Á¦11Àå ±â¾÷ °³¿ä

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

The global biomarker discovery outsourcing services market size is expected to reach USD 83.93 billion by 2034, according to a new study by Polaris Market Research. The report "Biomarker Discovery Outsourcing Services Market Size, Share, Trends, Industry Analysis Report: By Type (Predictive Biomarkers, Prognostic Biomarkers, Safety Biomarkers, and Surrogate Endpoints), Therapeutic Area, Discovery Phase, End Use, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Biomarker discovery outsourcing services involve contracting third-party organizations to identify, validate, and develop biomarkers that play a crucial role in disease diagnosis, drug development, and personalized medicine. These services are offered by contract research organizations (CROs), biotechnology firms, and specialized laboratories, providing pharmaceutical and healthcare companies access to advanced technologies such as next-generation sequencing, proteomics, and bioinformatics. By outsourcing biomarker discovery, companies can optimize research and development (R&D) efficiency, reduce operational costs, and accelerate the time-to-market for new therapies. The growing focus on precision medicine and targeted therapies has significantly increased the demand for these services, as biomarkers help in identifying patient-specific responses to treatments and improving clinical trial success rates. The biomarker discovery outsourcing services market is witnessing steady growth due to increasing research collaborations, rising healthcare investments, and advancements in biomarker-based diagnostics.

The biomarker discovery outsourcing services market is experiencing significant growth, fueled by advancements in technology, a robust pharmaceutical sector, and supportive regulatory frameworks. Key drivers include the increasing adoption of artificial intelligence (AI) and machine learning to enhance biomarker analysis, as well as the expansion of service portfolios to meet diverse research needs. Companies are also prioritizing strategic collaborations with drug developers to improve efficiency and competitiveness. The rising focus on personalized medicine and biomarker-driven drug development is further accelerating market expansion, creating opportunities for innovative solutions in disease detection and treatment optimization. As demand for precision medicine grows, the market is poised for continued progress, offering cutting-edge tools and services to advance biomedical research and therapeutic development.

Biomarker Discovery Outsourcing Services Market Report Highlights

By type, surrogate endpoints hold the largest market share. Surrogate endpoints serve as indirect measures representing clinical outcomes, enabling researchers to assess treatment efficacy and safety more efficiently during drug development.

By therapeutic area, oncology dominates the biomarker discovery outsourcing services market, driven by the increasing prevalence of cancer and the growing adoption of biomarker-driven drug development. The use of biomarkers in early cancer detection, prognosis, and treatment selection enhances the segment's significance in clinical research.

North America holds the largest market share. This dominance is driven by substantial R&D investments, a strong emphasis on precision medicine, and robust collaborations between pharmaceutical companies and contract research organizations (CROs).

Asia Pacific is experiencing the highest biomarker discovery outsourcing services market CAGR. This rapid expansion is attributed to increasing pharmaceutical R&D activities, a surge in clinical trial operations, and cost-effective outsourcing solutions available in countries such as China and India.

The biomarker discovery outsourcing services market key players include Laboratory Corporation of America Holdings (Labcorp), Charles River Laboratories International, Inc., Eurofins Scientific, Celerion, ICON plc, Parexel International (MA) Corporation, Proteome Sciences, Thermo Fisher Scientific Inc., Evotec, WuXi AppTec, GenScript ProBio, and Fujirebio Holdings Inc

Polaris Market Research has segmented biomarker discovery outsourcing services market report based on type, therapeutic area, discovery phase, end use, and region:

By Type Outlook (Revenue-USD Billion, 2020-2034)

Predictive Biomarkers

Prognostic Biomarkers

Safety Biomarkers

Surrogate Endpoints

By Therapeutic Area Outlook (Revenue-USD Billion, 2020-2034)

Oncology

Neurology

Cardiology

Autoimmune Diseases

Others

By Discovery Phase Outlook (Revenue-USD Billion, 2020-2034)

Biomarker Identification

Biomarker Validation

Biomarker Profiling

Biomarker Panel Development

Biomarker Selection

By End Use Outlook (Revenue-USD Billion, 2020-2034)

Pharmaceutical Companies

Biotechnology Companies

Others

By Regional Outlook (Revenue-USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

Suth Korea

Indnesia

Australia

Vietnam

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Suth Africa

Rest of Middle East & Africa

Latin America

Mexic

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

2. Executive Summary

3. Research Methodology

4. Global Biomarker Discovery Outsourcing Services Market Insights

5. Global Biomarker Discovery Outsourcing Services Market, by Type

6. Global Biomarker Discovery Outsourcing Services Market, by Therapeutic Area

7. Global Biomarker Discovery Outsourcing Services Market, by Discovery Phase

8. Global Biomarker Discovery Outsourcing Services Market, by End Use

9. Global Biomarker Discovery Outsourcing Services Market, by Geography

10. Competitive Landscape

11. Company Profiles

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â